BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23082771)

  • 21. ALK-negative anaplastic large cell lymphoma primarily involving the bronchus: a case report and literature review.
    Xu X
    Int J Clin Exp Pathol; 2014; 7(1):460-3. PubMed ID: 24427373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary gastrointestinal anaplastic large cell lymphoma.
    Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
    Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
    Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature.
    Cao Q; Liu F; Li S; Liu N; Li L; Li C; Peng T
    Diagn Pathol; 2016 Sep; 11(1):83. PubMed ID: 27612448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
    Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
    J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
    Ait-Tahar K; Damm-Welk C; Burkhardt B; Zimmermann M; Klapper W; Reiter A; Pulford K; Woessmann W
    Blood; 2010 Apr; 115(16):3314-9. PubMed ID: 20185586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
    Zhang W; Burton S; Wu S; Qian X; Rajeh MN; Schroeder K; Shuldberg M; Merando A; Lai JP
    In Vivo; 2017; 31(4):701-704. PubMed ID: 28652442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic large cell lymphoma, ALK-negative.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
    Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
    Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation of recurrent ALK-positive anaplastic large-cell lymphoma from common pattern to composite pattern (lymphohistiocytic and small-cell pattern) with a change in CD30 expression.
    Ji L; Liu C; Zhao S
    Int J Hematol; 2023 Jul; 118(1):131-134. PubMed ID: 36735219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
    Rigaud C; Knörr F; Brugières L; Woessmann W
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101444. PubMed ID: 36907641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
    Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
    Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small Cell Variant of Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma of the Dura Mimicking Tentorial Meningioma.
    Hirano Y; Miyawaki S; Satou M; Taoka K; Toyama K; Ikemura M; Tanaka R; Takayanagi S; Tanaka S; Nakatomi H; Kurokawa M; Saito N
    World Neurosurg; 2020 Jun; 138():169-173. PubMed ID: 32151774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma.
    Shen J; Medeiros LJ; Li S; Wang SA; Lin P; Khanlari M; Iyer SP; Yin CC; Tang G; Jorgensen JL; Hu S; Miranda RN; Xu J
    Hum Pathol; 2020 Apr; 98():1-9. PubMed ID: 32032618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
    Oregel KZ; Everett E; Zhang X; Nagaraj G
    Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
    Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.
    Norimatsu Y; Akatsuka T; Matsuoka A; Hamada T; Mori I; Shiomi T; Mori N; Onishi K; Togashi Y; Inoue N; Takeuchi K; Sugaya M
    J Dermatol; 2024 Jan; 51(1):120-124. PubMed ID: 37753577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.